Back to Search
Start Over
HMGB1 and TLR4 mediate skeletal muscle recovery in a murine model of hindlimb ischemia
- Source :
- Journal of vascular surgery. 58(2)
- Publication Year :
- 2012
-
Abstract
- BackgroundWe have previously shown that the danger signal high-mobility group box 1 (HMGB1) promotes angiogenesis when administered to ischemic muscle. HMGB1 signals through Toll-like receptor 4 (TLR4) as well as the receptor for advanced glycation end-products (RAGE). However, the actions of these receptors in ischemic injury and muscle recovery are not known. We hypothesize that TLR4 mediates tissue recovery and angiogenesis in response to ischemia.MethodsFemoral artery ligation was performed in control, TLR4 competent (C3H/HeOuJ) and incompetent (C3H/HeJ) mice, as well as RAGE knockout mice and their C57B6 control counterparts. In other experiments, control mice were pretreated with anti-HMGB1 neutralizing antibody before femoral artery ligation. After 2 weeks, limb perfusion was evaluated using laser Doppler perfusion imaging and reported as the ratio of blood flow in the ischemic to nonischemic limb. Muscle necrosis, fat replacement, and vascular density in the anterior tibialis muscle were quantified histologically. In vitro, TLR4 and RAGE expression was evaluated in human dermal microvascular endothelial cells in response to hypoxia. Human dermal microvascular endothelial cells treated with HMGB1 alone and in the presence of anti-TLR4 antibody were probed for phosphorylated extracellular signal-regulated kinase (ERK), a signaling molecule critical to endothelial cell (EC) angiogenic behavior.ResultsBoth anti-HMGB1 antibody as well as defective TLR4 signaling in HeJ mice resulted in prominent muscle necrosis 2 weeks after femoral artery ligation. Control HeOuJ mice had less necrosis than TLR4 incompetent HeJ mice, but a greater amount of fat replacement. In contrast to control C3H mice, control C57B6 mice demonstrated prominent muscle regeneration with very little necrosis. Muscle regeneration was not dependent on RAGE. While vascular density did not differ between strains, mice with intact RAGE and TLR4 signaling had less blood flow in ischemic limbs compared with mutant strains. In vitro, EC TLR4 expression increased in response to hypoxia while TLR4 antagonism decreased HMGB1-induced activation of extracellular signal-regulated kinase.ConclusionsBoth HMGB1 and TLR4 protect against muscle necrosis after hindlimb ischemia. However, muscle regeneration does not appear to be tied to vascular density. HMGB1 likely activates angiogenic behavior in ECs in vitro, and this activation may be modulated by TLR4. The improvement in blood flow seen in mice with absent TLR4 and RAGE signaling may suggest anti-angiogenic roles for both receptors, or vasoconstriction induced by TLR4 and RAGE mediated inflammatory pathways.Clinical RelevanceNonreconstructable peripheral artery disease causes significant functional disability and is associated with a high risk of limb loss. The mechanisms that govern muscle recovery and angiogenesis after ischemia are important to understand to improve medical therapy for patients who cannot have an intervention. This article evaluates the role of high-mobility group box 1 and the innate immune receptor Toll-like receptor 4 in mediating muscle recovery after ischemia. While high-mobility group box 1 has been shown to mediate end-organ damage in other clinical scenarios, it may also play an important role in regenerative processes such as myocyte regeneration and angiogenesis.
- Subjects :
- Male
Necrosis
Time Factors
Angiogenesis
Receptor for Advanced Glycation End Products
030204 cardiovascular system & hematology
Mice
0302 clinical medicine
Ischemia
Laser-Doppler Flowmetry
HMGB1 Protein
Phosphorylation
Receptors, Immunologic
Receptor
Extracellular Signal-Regulated MAP Kinases
Cells, Cultured
Mice, Knockout
0303 health sciences
Mice, Inbred C3H
biology
Hindlimb
Endothelial stem cell
Femoral Artery
medicine.anatomical_structure
medicine.symptom
Cardiology and Cardiovascular Medicine
Signal Transduction
medicine.medical_specialty
Perfusion Imaging
Neovascularization, Physiologic
HMGB1
Article
03 medical and health sciences
Internal medicine
medicine
Animals
Humans
Regeneration
Muscle, Skeletal
Ligation
030304 developmental biology
business.industry
Skeletal muscle
Endothelial Cells
medicine.disease
Antibodies, Neutralizing
Mice, Inbred C57BL
Toll-Like Receptor 4
Disease Models, Animal
Endocrinology
Regional Blood Flow
Immunology
biology.protein
Surgery
business
Vasoconstriction
Subjects
Details
- ISSN :
- 10976809
- Volume :
- 58
- Issue :
- 2
- Database :
- OpenAIRE
- Journal :
- Journal of vascular surgery
- Accession number :
- edsair.doi.dedup.....19e04af91a25732b6c3987245f441e03